Cite
Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer
MLA
Guiyang Jiang, et al. “Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer.” Cancers, vol. 13, no. 975, Feb. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cd81da3c68847b00cfa61019ec8f04e0&authtype=sso&custid=ns315887.
APA
Guiyang Jiang, Takuro Goto, Taichi Mizushima, Eiji Kashiwagi, George J. Netto, Yujiro Nagata, Hiroshi Miyamoto, Yuki Teramoto, Hiroki Ide, Satoshi Inoue, Alexander S. Baras, & Zhiming Yang. (2021). Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer. Cancers, 13(975).
Chicago
Guiyang Jiang, Takuro Goto, Taichi Mizushima, Eiji Kashiwagi, George J. Netto, Yujiro Nagata, Hiroshi Miyamoto, et al. 2021. “Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer.” Cancers 13 (975). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cd81da3c68847b00cfa61019ec8f04e0&authtype=sso&custid=ns315887.